Patents Assigned to Primal Therapies, Inc.
  • Patent number: 11491100
    Abstract: The present invention relates to non-toxic consumable compositions and formulations comprising chelator and base having synergistic effects on microbial metabolism and/or growth and/or pathogenic effectors and their use to promote and maintain health in mammals. The current invention also relates to non-toxic consumable compositions comprising more than one chelator and/or more than one base. The present invention further relates to methods for selecting said chelator and base composition and methods for detecting conditions in which selected compositions may be used. The present invention relates to the synergistic compositions and methods of their use for maintaining health, promoting health and treating diseases.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: November 8, 2022
    Assignee: Primal Therapies, Inc.
    Inventor: Emily A. Stein
  • Patent number: 10117823
    Abstract: Non-toxic consumable compositions and formulations having chelator and base are disclosed with synergistic effects on microbial metabolism and/or growth and/or pathogenic effectors and their use to promote and maintain health in mammals. The non-toxic consumable compositions have more than one chelator and/or more than one base. Methods for selecting said chelator and base composition and methods for detecting conditions in which selected compositions may be used are also disclosed. The synergistic compositions and methods can be used for maintaining health, promoting health and treating diseases.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 6, 2018
    Assignee: Primal Therapies, Inc.
    Inventor: Emily A. Stein